{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T07:46:19Z","timestamp":1784360779737,"version":"3.55.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Huazhong Univ. Sci. Technol. [Med. Sci.]"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1007\/s11596-014-1247-7","type":"journal-article","created":{"date-parts":[[2014,2,5]],"date-time":"2014-02-05T02:52:06Z","timestamp":1391568726000},"page":"146-150","source":"Crossref","is-referenced-by-count":43,"title":["Association of HLA-B*1502 and *1511 allele with antiepileptic drug-induced Stevens-Johnson syndrome in central China"],"prefix":"10.1007","volume":"34","author":[{"given":"Dan","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-hua","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-sheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-lian","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-sheng","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ge-fei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-hua","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-hui","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,2,6]]},"reference":[{"issue":"19","key":"1247_CR1","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1056\/NEJM199411103311906","volume":"331","author":"JC Roujeau","year":"1994","unstructured":"Roujeau JC, Stern RS. Severe adverse cutaneous reactions to drugs. New Engl J Med, 1994,331(19):1272\u20131285","journal-title":"New Engl J Med"},{"issue":"4","key":"1247_CR2","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/01.fpc.0000199500.46842.4a","volume":"16","author":"SI Hung","year":"2006","unstructured":"Hung SI, Chung WH, Jee SH, et al. Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions. Pharmacogenet Genomics, 2006,16(4):297\u2013306","journal-title":"Pharmacogenet Genomics"},{"issue":"6","key":"1247_CR3","first-page":"15","volume":"13","author":"KS Lim","year":"2008","unstructured":"Lim KS, Kwan P, Tan CT. Association of HLA-B*1502 allele and carbamazepine-induced severe adverse cutaneous drug reaction among Asians, a review. Neurology Asia, 2008,13(6):15\u201321","journal-title":"Neurology Asia"},{"issue":"2","key":"1247_CR4","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1365-4632.2010.04745.x","volume":"50","author":"CC Chang","year":"2011","unstructured":"Chang CC, Too CL, Murad S, et al. Association of HLAB*1502 allele with carbamazepine-induced toxic epidermal necrolysis and Stevens-Johnson syndrome in the multi-ethnic Malaysian population. Int J Dermatol, 2011,50(2):221\u2013224","journal-title":"Int J Dermatol"},{"issue":"5","key":"1247_CR5","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1093\/hmg\/ddq537","volume":"20","author":"T Ozeki","year":"2011","unstructured":"Ozeki T, Mushiroda T, Yowang A, et al. Genome-wide association study identifies HLAA*3101 allele as a genetic risk factor for carbamazepine-induced cutaneous adverse drug reactions in Japanese population. Hum Mol Genet, 2011,20(5):1034\u20131041","journal-title":"Hum Mol Genet"},{"issue":"5","key":"1247_CR6","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1111\/j.1528-1167.2007.01022.x","volume":"48","author":"CB Man","year":"2007","unstructured":"Man CB, Kwan P, Baum L, et al. Association between HLA-B*1502 allele and antiepileptic drug-induced cutaneous reactions in Han Chinese. Epilepsia, 2007,48(5): 1015\u20131018","journal-title":"Epilepsia"},{"issue":"5","key":"1247_CR7","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1399-0039.1995.tb03127.x","volume":"46","author":"M Bunce","year":"1995","unstructured":"Bunce M, O\u2019Neill CM, Barnardo MC, et al. Phototyping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP). Tissue Antigens, 1995,46(5):355\u2013367","journal-title":"Tissue Antigens"},{"issue":"4","key":"1247_CR8","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/sj.tpj.6500356","volume":"6","author":"C Lonjou","year":"2006","unstructured":"Lonjou C, Thomas L, Borot N, et al. RegiSCAR Group. A marker for Stevens-Johnson syndrome ethnicity matters. Pharmacogenomics J, 2006,6(4):265\u2013268","journal-title":"Pharmacogenomics J"},{"issue":"6982","key":"1247_CR9","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/428486a","volume":"428","author":"WH Chung","year":"2004","unstructured":"Chung WH, Hung SI, Hong HS, et al. Medical genetics: a marker for Stevens-Johnson syndrome. Nature, 2004,428(6982):486","journal-title":"Nature"},{"issue":"12","key":"1247_CR10","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1111\/j.1528-1167.2008.01719.x","volume":"49","author":"C Locharernkul","year":"2008","unstructured":"Locharernkul C, Loplumlert J, Limotai C, et al. Carbamazepine and phenytoin induced Stevens-Johnson syndrome is associated with HLA-B*1502 allele in Thai population. Epilepsia, 2008,49(12):2087\u20132091","journal-title":"Epilepsia"},{"issue":"2","key":"1247_CR11","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1528-1167.2009.02269.x","volume":"51","author":"H Ikeda","year":"2010","unstructured":"Ikeda H, Takahashi Y, Yamazaki E, et al. HLA class I markers in Japanese patients with carbamazepine-induced cutaneous adverse reactions. Epilepsia, 2010,51(2): 297\u2013300","journal-title":"Epilepsia"},{"issue":"6","key":"1247_CR12","doi-asserted-by":"crossref","first-page":"813","DOI":"10.2217\/14622416.7.6.813","volume":"7","author":"A Alfirevic","year":"2006","unstructured":"Alfirevic A, Jorgensen AL, Williamson PR, et al. HLA-B locus in Caucasian patients with carbamazepine hypersensitivity. Pharmacogenomics, 2006,7(6):813\u2013818","journal-title":"Pharmacogenomics"},{"issue":"6","key":"1247_CR13","doi-asserted-by":"crossref","first-page":"579","DOI":"10.4103\/0378-6323.57718","volume":"75","author":"TY Mehta","year":"2009","unstructured":"Mehta TY, Prajapati LM, Mittal B, et al. Association of HLA-B*1502 allele and carbamazepine-induced Stevens-Johnson syndrome among Indians. Indian J Dermatol Venereol Leprol, 2009,75(6):579\u2013582","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"3","key":"1247_CR14","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.yebeh.2010.08.007","volume":"19","author":"XT Wu","year":"2010","unstructured":"Wu XT, Hu FY, An DM, et al. Association between carbamazepine-induced cutaneous adverse drug reactions and the HLA-B*1502 allele among patients. Epilepsy Behav, 2010,19(3):405\u2013408","journal-title":"Epilepsy Behav"},{"issue":"5","key":"1247_CR15","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1111\/j.1528-1167.2010.02533.x","volume":"51","author":"W Tassaneeyakul","year":"2010","unstructured":"Tassaneeyakul W, Tiamkao S, Jantararoungtong T, et al. Association between HLA-B*1502 and carbamazepine-induced severe cutaneous adverse drug reactions in a Thai population. Epilepsia, 2010,51(5):926\u2013930","journal-title":"Epilepsia"},{"issue":"9","key":"1247_CR16","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1007\/s00228-011-1009-4","volume":"67","author":"Y Zhang","year":"2011","unstructured":"Zhang Y, Wang J, Zhao LM, et al. Strong association between HLA-B*1502 and carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in mainland Han Chinese patients. Eur J Clin Pharmacol, 2011,67(9):885\u2013887","journal-title":"Eur J Clin Pharmacol"},{"issue":"6","key":"1247_CR17","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.seizure.2011.02.003","volume":"20","author":"Q Wang","year":"2011","unstructured":"Wang Q, Zhou JQ, Zhou LM, et al. Association between HLA-B*1502 allele and carbamazepine-induced severe cutaneous adverse reactions in Han people of southern China mainland. Seizure, 2011,20(6):446\u2013448","journal-title":"Seizure"},{"issue":"1","key":"1247_CR18","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1742-7843.2012.00868.x","volume":"111","author":"YW Shi","year":"2012","unstructured":"Shi YW, Min FL, Qin B, et al. Association between HLA and Stevens-Johnson syndrome induced by carbamazepine in Southern Han Chinese: genetic markers besides B*1502? Basic Clin Pharmacol Toxicol, 2012,111(1):58\u201364","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"3","key":"1247_CR19","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1533-2500.2011.00479.x","volume":"12","author":"K Kulkantrakorn","year":"2012","unstructured":"Kulkantrakorn K, Tassaneeyakul W, Tiamkao S, et al. HLA-B*1502 strongly predicts carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Thai patients with neuropathic pain. Pain Pract, 2012,12(3):202\u2013208","journal-title":"Pain Pract"},{"issue":"12","key":"1247_CR20","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1111\/j.1528-1167.2010.02766.x","volume":"51","author":"N Kaniwa","year":"2010","unstructured":"Kaniwa N, Saito Y, Aihara M, et al. HLA-B*1511 is a risk factor for carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Japanese patients. Epilepsia, 2010,51(12):2461\u20132465","journal-title":"Epilepsia"},{"issue":"6","key":"1247_CR21","doi-asserted-by":"crossref","first-page":"489","DOI":"10.2165\/00002018-199921060-00005","volume":"21","author":"SR Knowles","year":"1999","unstructured":"Knowles SR, Shapiro LE, Shear NH. Anticonvulsion hypersensitivity syndrome: incidence, prevention and management. Drug Saf, 1999,21(6):489\u2013501","journal-title":"Drug Saf"},{"issue":"19","key":"1247_CR22","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1212\/01.wnl.0000334295.50403.4c","volume":"71","author":"LJ Hirsch","year":"2008","unstructured":"Hirsch LJ, Arif H, Nahm EA, et al. Cross-sensitivity of skin rashes with antiepileptic drug use. Neurology, 2008,71(19),1527\u20131534","journal-title":"Neurology"},{"issue":"23","key":"1247_CR23","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.eplepsyres.2008.04.003","volume":"80","author":"S Alvestad","year":"2008","unstructured":"Alvestad S, Lydersen S, Brodtkorb E. Cross-reactivity pattern of rash from current aromatic antiepileptic drugs. Epilepsy Res, 2008,80(23):194\u2013200","journal-title":"Epilepsy Res"}],"container-title":["Journal of Huazhong University of Science and Technology [Medical Sciences]"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-014-1247-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11596-014-1247-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-014-1247-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T23:35:49Z","timestamp":1716507349000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11596-014-1247-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["1247"],"URL":"https:\/\/doi.org\/10.1007\/s11596-014-1247-7","relation":{},"ISSN":["1672-0733","1993-1352"],"issn-type":[{"value":"1672-0733","type":"print"},{"value":"1993-1352","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2]]}}}